Preferred Label : Stage I Lung Adenocarcinoma AJCC v7;
NCIt synonyms : Stage I Lung Adenocarcinoma; Lung Adenocarcinoma, Stage I; Stage I Adenocarcinoma of Lung; Stage I Adenocarcinoma of the Lung;
NCIt definition : Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung
cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung
or visceral pleura and without bronchoscopic evidence of invasion more proximal than
the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor
of any size with its invasive component limited to the bronchial wall, which may extend
proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a
tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung
or visceral pleura and without bronchoscopic evidence of invasion more proximal than
the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor
size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph
metastasis. M0: No distant metastasis. (AJCC 7th ed.);
Neoplastic status : Malignant;
Origin ID : C8759;
UMLS CUI : C0854985;
Currated CISMeF NLP mapping
- Disease excludes abnormal cell
- Disease may have findings
- Excludes anatomical site(s)
- Has associated anatomic sites
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
- disease_mapped_to_gene
- disease_may_have_cytogenetic_abnormality
- disease_may_have_molecular_abnormality
